Clinical observation and psychological intervention on the treatment of severe heart failure by pumping vasoactive drugs under ECG monitoring
10.3969/j.issn.1005-1678.2017.10.121
- VernacularTitle:心电监护下泵入血管活性药物治疗重症心力衰竭的临床观察和心理干预
- Author:
Hong LI
1
;
Yan CHEN
Author Information
1. 杭州市中医院 重症监护室
- Keywords:
ECG monitoring;
vasoactive drugs;
severe heart failure
- From:
Chinese Journal of Biochemical Pharmaceutics
2017;37(10):278-279
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analyze the clinical observation and psychological intervention of the vasoactive drugs in the treatment of severe heart failure under ECG monitoring. Methods 100 patients with severe heart failure treated in our hospital from February 2015 to August 2016 were selected as the research object. They were randomly divided into the control group and the experimental group, with 50 patients in each group. The control group was treated with conventional treatment, including oxygen therapy and cardiac and diuretic therapy, the experimental group were given ECG monitoring and infusion of vasoactive drug therapy, using sodium nitroprusside drugs, and psychological intervention on the mental status of patients, strengthen communication and exchanges with patients, increasing confidence in treatment and the treatment compliance of patients. The clinical indexes of the experimental group and the control group were compared and analyzed. Results After the corresponding treatment, the number of invalid cases in the experimental group was 5 cases, the number of effective cases was 30 cases, and the number of effective cases was 15 cases. The number of invalid cases in the control group was 9 cases, the effective number was 27 cases, and the effective cases were 14 cases. The effective rate of treatment in the experimental group was 90%, which was significantly higher than that in the control group, and the effective rate was 82%, with statistical difference (P<0.05). There were no obvious adverse reactions in the experimental group and the control group. Conclusion The application of vasoactive drugs under ECG monitoring in the treatment of severe heart failure has better clinical efficacy and higher safety.
